1 / 1

Orciprenaline Sulphate

Orciprenaline Sulphate . Form : A white crystalline powder MW : 2(C 11 H 17 NO 3 ) . H 2 SO 4 = 520.29 Melting point : about 205°C When treating asthma it is given by mouth in a dose of 20mg four times daily .

lucie
Download Presentation

Orciprenaline Sulphate

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orciprenaline Sulphate Form: A white crystalline powder MW: 2(C11H17NO3).H2SO4 = 520.29 Melting point: about 205°C When treating asthma it is given by mouth in a dose of 20mg four times daily. Orciprenaline sulphate also comes in the form of an inhaler or in severe cases of bronchiospasm it can be administered directly as an intramuscular injection. Orciprenalinesuphate, being only partially selective, affects receptors elsewhere in the body and can cause many undesirable side-effects such as arrhythmias, tachycardias and anxiety attacks. A Public Assessment report published by the MHRA (Medicines and Healthcare products Regulatory Agency) in November 2009 decided that orciprenalinesulphate (Alupent®) should no longer be used in the treatment of asthma. The MHRA is currently working with the manufacturer to carry out a voluntary withdrawal of Alupent® over the next year.

More Related